Hospital AI Lab Praktikal na impormasyon sa medical AI para sa mga ospital sa Pilipinas

Na-update:

Medical technology at pananaliksik sa Pilipinas

Ano ang inilalathala at sinusubok ngayon ng mga doktor at mananaliksik sa Pilipinas? Kinokolekta ng pahinang ito ang mga papel na may kaakibat na institusyon sa Pilipinas sa mga may-akda at ang mga drug trial na may lugar doon, mula lamang sa nakaraang 12 buwan, sa tatlong pangkat: surgical technique, bagong gamot at therapy, at mga sakit.

Panahon: 2025-11-16 hanggang 2026-11-16 · awtomatikong ina-update kada linggo

Paano basahin ang pahinang ito
  • Awtomatikong listahan ito ng pamagat, journal, petsa at link mula sa PubMed at ClinicalTrials.gov. Hindi namin kinokopya ang abstract o teksto ng papel, at hindi pa namin sinusuri ang mga natuklasan.
  • Hindi patunay na epektibo o ligtas ang isang gamutan ang pagkakaroon ng papel o trial, at hindi ito payong medikal. Kausapin ang inyong clinician tungkol sa anumang gamutan.
  • Ang “papel mula sa Pilipinas” ay nangangahulugang hindi bababa sa isang kaakibat na institusyon ng may-akda ang nagbabanggit sa bansa; hindi ito nangangahulugang doon ginawa ang buong pag-aaral.
  • Ipinapakita ang mga pamagat sa orihinal na wika (karamihan ay Ingles).

Mga surgical technique

Mga papel tungkol sa minimally invasive, robot-assisted, endoscopic, joint replacement at transplant

Ipinapakita ang pinakabagong 12 mula sa 75 na tugma

  1. Robotic and open repair of complex ventral and incisional hernias with the Tissue Approximating System (TAS): a pilot feasibility study

    J Robot Surg 2026-11-10 Sawyer MAJ, Zucchini N, Koutentakis M et al. PMID 43007578

  2. Pre-hospital time and risk of perforation in patients with acute appendicitis in 112 countries (AlliGatOr): an international, prospective, observational cohort study

    Lancet Glob Health 2026-09-23 Anyomih TTK, Aregawi AB, Calvache JA et al. PMID 42777751

  3. Learning curve for second-stage laparoscopic Fowler-Stephens orchidopexy: an exploratory CUSUM analysis with prospective ultrasonographic follow-up

    World J Urol 2026-09-22 Kwok PPL, Wong M, Ming J et al. PMID 42771177

  4. Plasma ATR-FTIR spectroscopy combined with machine learning for nasopharyngeal carcinoma classification

    Spectrochim Acta A Mol Biomol Spectrosc 2026-09-21 Tomas RC, Suzuki Y, Magno GM et al. PMID 42785009

  5. Technical feasibility and early outcomes of single-port robotic mediastinal mass resection through subxiphoid, intercostal, and subcostal approaches

    J Robot Surg 2026-09-21 Yang YH, Dung NM, Jang DS et al. PMID 42766181

  6. A decade of survival in recurrent nonfunctioning oncocytic adrenocortical carcinoma in a young Filipina

    JCEM Case Rep 2026-09-16 Jacobo RJ, de Leon QF, Lim PW et al. PMID 42751079

  7. International Travel for Organ Transplantation: 2024 Multinational Survey of Routes, Organs, and Donor Types

    Transplantation 2026-09-10 Martin DE, Jiang Y, Lundgren A et al. PMID 42717290

  8. Treatment of Mantle Cell Lymphoma in Asia: Updated Consensus from the Asian Lymphoma Study Group

    Cancer Res Treat 2026-09-09 Chan JY, Lim ST, Ong CK et al. PMID 42722392

  9. Low-pressure pneumoperitoneum in robot-assisted radical prostatectomy: a systematic review, meta-analysis and trial sequential analysis of randomized controlled trials

    Int Urol Nephrol 2026-09-09 Ramirez-Paliza Y, Kasimieh O, Sanha V et al. PMID 42714791

  10. Current status of fertility preservation for borderline ovarian tumor in Asian regions: results from ASGO-special task force for fertility preservation; part I. Fertility-sparing treatment for borderline ovarian tumor

    J Gynecol Oncol 2026-09-07 Kuji S, Muhammad S, Kumari S et al. PMID 42750301

  11. Preoperative Medial Proximal Tibial Angle of Less Than 84° Does Not Compromise Two-Year Clinical Outcomes After Unrestricted Kinematic Alignment Total Knee Arthroplasty: A Propensity Score-Matched Study

    J Arthroplasty 2026-09-04 Ng Y, Lim WSR, Lam LZL et al. PMID 42697451

  12. Early Secondary Graft Failure After Complete Donor Chimerism with Autologous Recovery Following Haploidentical HSCT for Relapsed B-ALL

    Blood Cell Ther 2026-08-25 Amadore RA Jr, Bonifacio LB PMID 42707771

Bagong gamot at therapy (mga papel)

Phase 1–3 at randomized na pagsubok ng gamot, antibody, bakuna at bagong therapy

Ipinapakita ang pinakabagong 12 mula sa 17 na tugma

  1. Phase 2 trial to evaluate the safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine (IVT-PCV25) in infants

    Vaccine 2026-10-21 Bravo L, Bermal N, Alberto E et al. PMID 42906503

  2. Therapeutic value of continuous subcutaneous insulin infusion with electrolyte supplementation for pediatric diabetic ketoacidosis

    Eur J Pediatr 2026-10-02 Li W, Zhang H, Li Q et al. PMID 42825942

  3. Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event

    N Engl J Med 2026-08-29 Gibson CM, Steg PG, Bahit MC et al. PMID 42670965

  4. Characterization of vaccine viremia, attenuation reversion, and safety: Combined results from the TAK-003 dengue vaccine clinical development program

    Vaccine 2026-07-24 Tricou V, Saez-Llorens X, Kosalaraksa P et al. PMID 42497670

  5. Long-term safety and efficacy of voclosporin in Asian patients with lupus nephritis: A post hoc analysis of the AURORA 2 trial

    Mod Rheumatol 2026-06-30 Atsumi T, Navarra S, Truman M et al. PMID 41410387

  6. Web-Based Gamified Auditory-Cognitive Dual-Task Training for Older Adults With Age-Related Hearing Loss: Pilot Randomized Controlled Trial

    JMIR Aging 2026-06-16 Zhao IY, Leung AYM, Li C et al. PMID 42302249

  7. Efficacy and safety of photothermal biomodulated platelet-rich plasma versus standard platelet-rich plasma for facial rejuvenation: a prospective split-face randomized study

    Sci Rep 2026-06-01 Wanitphakdeedecha R, Ollero MPGCR, Bhorntarakcharoen W et al. PMID 42225690

  8. Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial

    Lancet 2026-05-30 Lenz G, Trněný M, Burke JM et al. PMID 42217458

  9. Efficacy, immunogenicity, and safety of a cell culture-derived quadrivalent influenza vaccine compared with a non-influenza vaccine in infants and children across five influenza seasons: a phase 3, multinational, observer-blind, randomised controlled trial

    Lancet Child Adolesc Health 2026-05-01 Põder A, Ong-Lim AL, Rivera Medina DM et al. PMID 41962984

  10. Immunogenicity and safety of MF59-adjuvanted H5N1 pandemic influenza vaccine in healthy infants and children: a phase 2 randomized, observer-blind, multicenter study

    Vaccine 2026-03-26 Põder A, Trinidad-Aseron M, Van Twuijver E et al. PMID 41895156

  11. Efficacy, Immunogenicity, and Safety of an Investigational Maternal Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine

    Clin Infect Dis 2026-02-09 Banooni P, Gonik B, Epalza C et al. PMID 39879629

  12. Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial

    Ann Oncol 2026-02-01 Harbeck N, Modi S, Pusztai L et al. PMID 41130363

Mga drug trial na nagsimula sa nakaraang taon

Mga pag-aaral ng gamot na nakarehistro sa ClinicalTrials.gov na may lugar sa Pilipinas (pinakabago muna)

Ipinapakita ang pinakabagong 12 mula sa 17 na tugma

  1. Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

    NCT06800248 Phase: Phase 3 Nagsimula: 2026-11-06 Sponsor: Swiss Tropical & Public Health Institute Mga kondisyon: Trichuris Trichiura; Infection, Hookworm Infection, Ascaris Lumbricoides Infection Gamot / interbensyon: emodepside (BAY 44-4400), Mebendazole 100 MG

  2. A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

    NCT07595042 Phase: Phase 2 Nagsimula: 2026-10-30 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Mga kondisyon: Tuberculosis Gamot / interbensyon: Isoniazid, Rifampin

  3. Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction

    NCT07172659 Phase: Phase 2 Nagsimula: 2026-10-12 Sponsor: Medicines Development for Global Health Mga kondisyon: Erythema Nodosum Leprosum Gamot / interbensyon: Dovramilast, Prednisolone

  4. Therapeutics for Moderate and Severe Dengue

    NCT07543458 Phase: Phase 3 Nagsimula: 2026-10-01 Sponsor: Oxford University Clinical Research Unit, Vietnam Mga kondisyon: Dengue, Severe Dengue, Mosquito-Borne Diseases Gamot / interbensyon: Placebo, Dexamethasone

  5. Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer

    NCT07851025 Phase: Phase 3 Nagsimula: 2026-09-16 Sponsor: AstraZeneca Mga kondisyon: Epithelial Ovarian Cancer Gamot / interbensyon: Torvutatug samrotecan, Bevacizumab

  6. A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

    NCT07624305 Phase: Phase 3 Nagsimula: 2026-09-01 Sponsor: AstraZeneca Mga kondisyon: Renal Insufficiency, Chronic Gamot / interbensyon: Balcinrenone/dapagliflozin, Dapagliflozin

  7. Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

    NCT07691970 Phase: Phase 3 Nagsimula: 2026-08-31 Sponsor: AstraZeneca Mga kondisyon: Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus Gamot / interbensyon: Anifrolumab, Anifrolumab

  8. A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

    NCT07753993 Phase: Phase 3 Nagsimula: 2026-08-21 Sponsor: AstraZeneca Mga kondisyon: Chronic Kidney Disease Gamot / interbensyon: Elecoglipron, Placebo

  9. A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

    NCT07775404 Phase: Phase 3 Nagsimula: 2026-08-21 Sponsor: AstraZeneca Mga kondisyon: Obesity, Overweight Gamot / interbensyon: Elecoglipron, Placebo

  10. Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Patient Access Program

    NCT07562347 Nagsimula: 2026-08-07 Sponsor: IR INNOVATE RESEARCH PRIVATE LIMITED Mga kondisyon: Advanced Solid Tumor Gamot / interbensyon: Envafolimab

  11. A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

    NCT07497087 Phase: Phase 3 Nagsimula: 2026-07-27 Sponsor: Boehringer Ingelheim Mga kondisyon: Systemic Sclerosis Gamot / interbensyon: Placebo matching nerandomilast formulation 1, Placebo matching nerandomilast formulation 2

  12. Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

    NCT06705478 Phase: Phase 2 Nagsimula: 2026-05-17 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Mga kondisyon: Major Depressive Disorder, Mild Neurocognitive Disorder, HIV Gamot / interbensyon: Pramipexole ER, Escitalopram

Mga sakit at pag-aaral sa populasyon

Mga nationwide cohort, registry at population-based na pag-aaral sa insidensya at prevalence

Ipinapakita ang pinakabagong 12 mula sa 389 na tugma

  1. Estimated Usual Nutrient Intakes and Nutrient Inadequacy Among Schoolchildren in Rural Communities in the Philippines

    Food Nutr Bull 2026-11-13 Chung YH, Calayo-Garvilles G, Reario MFD et al. PMID 43023415

  2. Regimens of vitamin D supplementation for women during pregnancy

    Cochrane Database Syst Rev 2026-11-11 Trak-Fellermeier MA, Palma Molina XE, Huey SL et al. PMID 43012372

  3. Real-World Treatment Patterns and Unmet Needs of Patients with Locally Advanced Cervical Cancer in Mainland China

    Oncol Ther 2026-11-10 Peng P, Goh JC, Domingo EJ et al. PMID 43009689

  4. Serum MMP-10 levels predict incident inflammatory bowel disease: an observational analysis from the PURE study

    J Crohns Colitis 2026-11-07 Wong ECL, Reinisch W, Moayyedi P et al. PMID 43034053

  5. Germinate-to-Exterminate: Precrop Stimulation of Verticillium dahliae Microsclerotia Germination by Root Exudates as a Novel Strategy for Sustainable Control of Verticillium Wilt

    Plant Dis 2026-11-07 Anand U, Ur Rehman F, Amponsah J et al. PMID 42334936

  6. Symptomatic Vertebral Artery Loop Formations: A Scoping Review of Epidemiology, Pathogenesis, and Treatment

    Neurosurg Pract 2026-11-05 Tiangco DAL, Sih IMY PMID 42985640

  7. Chronic inflammation and multiple dimensions of aging among women in the Philippines

    J Gerontol A Biol Sci Med Sci 2026-11-05 McDade TW, Carrera S, Ryan CP et al. PMID 42841728

  8. Childhood and Adolescent Cancer Burden in 2024 and Projections to 2050

    Pediatr Blood Cancer 2026-11-04 Tawfiles D, Jain U, Lam CG et al. PMID 42980088

  9. Epidemiological Characteristics and Clinical Outcomes of Vaccine-associated Urticaria: A Retrospective Cross-sectional Analysis of the Vaccine Adverse Event Reporting System Database (1990-2025)

    Ann Afr Med 2026-11-03 Chandrashekar C, Peachiappan PA, Jandwa H et al. PMID 42974681

  10. Burden and temporal trends of four major road traffic injuries in Asia-Pacific, 1990-2023: A GBD-based study

    Traffic Inj Prev 2026-11-02 Xiang Y, Huang W, Palitnonkiat V et al. PMID 42969862

  11. Global, Regional, and National Burden of Heart Failure, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023

    JAMA Cardiol 2026-11-01 GBD 2023 Heart Failure Collaborators, Johnson CO, Abbasi M et al. PMID 42814432

  12. Artificial intelligence-enabled interventions for smoking cessation: a systematic review and meta-analysis of randomised controlled trials

    Int J Med Inform 2026-10-29 Adebisi YA, Alhur AA, Ogunkola IO et al. PMID 42970911

Sanggunian: PubMed · ClinicalTrials.gov